Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
about
Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylaseAntibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung diseasePrevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant.Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.Dendritic cells, B cells and the regulation of antibody synthesis.Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.Oral tolerance.Nature and function of gastrointestinal antigen-presenting cells.Mature T cell seeks antigen for meaningful relationship in lymph node.Recipient B cells are not required for graft-versus-host disease induction.Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.Antigen presentation to naive CD4 T cells in the lymph node.Uptake and presentation of myelin basic protein by normal human B cells.Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritisDisparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.B lymphocytes regulate airway granulocytic inflammation and cytokine production in a murine model of fungal allergic asthma.The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node.Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells.Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.The molecular makeup and function of regulatory and effector synapses.Regulatory function of in vivo anergized CD4(+) T cellsImmunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective.How B cells shape the immune response against Mycobacterium tuberculosis.B cell depletion in autoimmune diabetes: insights from murine models.Environmental enrichment alters splenic immune cell composition and enhances secondary influenza vaccine responses in mice.Dendritic cell subsets as vectors and targets for improved cancer therapyDendritic cells: are they clinically relevant?Mechanisms regulating dendritic cell specification and developmentDendritic cells and immunity against cancer.Recent developments in cancer vaccinesB-cell targeted therapeutics in clinical development.Efficient Culture of Human Naive and Memory B Cells for Use as APCs.IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells.
P2860
Q28731379-CF99793C-A321-4ECB-A274-9EE97C76F60DQ33247469-A23F4173-9A8B-4F2D-8E08-E8678F43AF92Q33366487-E725E5E3-400F-469C-9FE1-B960F04419BAQ33368912-2A1BF873-6BDB-4227-ADF4-054BA45FC219Q33731623-3C9B3212-418B-48B3-A636-529611A7DBFFQ33815470-A53EE0F1-983F-4840-B0EB-1F0F8B69CF2EQ34035564-D3A38AB3-8E92-4C22-9E82-01121971A069Q34058680-D8C31BA5-55DA-46D4-B09E-A753DC043D1DQ34215953-DA1463AE-FB39-492C-8FFB-3A1D0FE2ADEDQ34235880-C359FF53-3087-42ED-B639-877B7D73A92FQ35104223-57CC0761-A814-4D12-8857-F7A43BF9C258Q35173245-CD7348A3-FBF8-45F3-9AFF-A6A43469B42BQ35187925-5E0FBD24-3D44-4D86-A14B-BD76A88BE65FQ35424431-43E56765-1A9D-4AC2-8921-4B5A963E8EDCQ35891605-699E219A-6A22-452A-BCA4-C1CF2C4E920CQ36052152-C6156C93-C87F-4D7C-A142-A9F2F81EB18AQ36143507-0C8651AF-B00D-4878-A1B0-B7A2402EF7FCQ36256534-92CFEC56-B156-4189-867C-ED69D75753A5Q36302587-C0472EE4-72D2-4C4E-8B24-4D9FAC41013FQ36368355-C3C9D719-6BFF-4B5B-9384-E4AC62EA2432Q36368410-0C7142C7-31A7-4FCE-B678-88B7E32FB29CQ36371218-493D2834-F3E0-4E5A-9EE9-B9605F71AF08Q36401207-0E959E24-C905-47C4-818C-E9B609CB294DQ36404256-E0932688-78AE-4E80-84CE-A33C0356AE0CQ36526337-FA2DCFB1-3979-4668-ADC4-B81E6EE19666Q36877341-35B9CDA0-C322-4C57-B1DE-B6B58415B472Q37113443-9726F8BD-9FFB-4414-9A51-1268597D4542Q37207756-A50D210E-60D2-49F8-81CF-12AB49BF3CB9Q37383963-B25D7FE9-FD3F-4289-84AE-3BA1CFE3E6EAQ37720217-D36FA9C0-73BF-4A60-B736-F65D3DC7A63BQ37728996-2D23B599-3F99-43FF-9FA6-C8956DFA91CEQ37758502-1106EB26-6088-470A-B6E7-39E3917C5427Q37778692-26BD177A-F102-4192-8519-63CC240380B2Q37802420-F1CC1D72-3185-4380-941F-96927FC441F9Q37821074-8976CDBA-6506-4AD5-9EF9-5ADDC6C6F228Q37830226-47B3701B-40F8-49FA-BA81-2FBBE5EFEE7CQ38097162-CA5D1298-F62D-4511-BEFF-9523094152A4Q38732881-616F9A07-4C40-4455-BFC8-B06AF917EE3CQ40070176-CA980730-32B3-460A-A854-288FBE6A5767Q42767669-FBA9A9EF-27A3-4520-9663-CF5E05B2EEA0
P2860
Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Antigen-unspecific B cells and ...... exposure in vivo or in vitro.
@ast
Antigen-unspecific B cells and ...... exposure in vivo or in vitro.
@en
type
label
Antigen-unspecific B cells and ...... exposure in vivo or in vitro.
@ast
Antigen-unspecific B cells and ...... exposure in vivo or in vitro.
@en
prefLabel
Antigen-unspecific B cells and ...... exposure in vivo or in vitro.
@ast
Antigen-unspecific B cells and ...... exposure in vivo or in vitro.
@en
P2860
P356
P1476
Antigen-unspecific B cells and ...... n exposure in vivo or in vitro
@en
P2093
P2860
P304
P356
10.1084/JEM.186.5.673
P407
P577
1997-08-01T00:00:00Z